Critical Care for Multiple Organ Failure Secondary to XXXX in the United States.

@entity1 @entity2598 @entity3124 @entity177 @entity881
OBJECTIVE: This report describes three @entity1 with @entity2598 who were treated in the United States and developed for severe @entity3124 and @entity881 . The @entity1 received mechanical ventilation, renal replacement therapy, invasive monitoring, vasopressor support, and investigational therapies for @entity2598 . DATA SOURCES: @entity1 medical records from three tertiary care centers (Emory University Hospital, University of Nebraska Medical Center, and Texas Health Presbyterian Dallas Hospital). STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: Not applicable. CONCLUSION: In the severe form, @entity1 with @entity2598 may require life-sustaining therapy, including mechanical ventilation and renal replacement therapy. In conjunction with other reported cases, this series suggests that respiratory and @entity177 may occur in severe @entity2598 , especially in @entity1 burdened with high viral loads. @entity2598 complicated by @entity881 can be survivable with the application of advanced life support measures. This collective, multicenter experience is presented with the hope that it may inform future treatment of @entity1 with @entity2598 requiring critical care treatment.
